Uncategorised

Radiation Equipment Exposure

Radiation Equipment Exposure.

  1. Simulators- Simulator C.T. (Phabeus Mecaserto), C.T Simulator  (Somatom    Emotion).
  2. Tele Cobalt- Theratron 780, Theratron 780 E.
  3.  LINACS- Varian DBX, 40P MLCs, (6MV), Varian DHX (6&15. MVs) ,Siemens Primus and Primus Plus (dual energy) Capable of delivering IMRT.  , Electron –6,9,12,15 & 18.MeVs.
  4. IGRT

GAMMA KNIFE, PROTON THERAPY(M.D Anderson Cancer Centre Houston , Texas, U.S.A)   ONLY FEMALE  INDIAN 

  1. Brachytherapy- Nucleoteron, Microselectron HDR.
  2.  Mould Room.

Qualification

Details of Qualification:

Degree

College

MBBS including Internship

Govt Medical College, Jammu,INDIA

Field Medical Officer

1999-2002

1.M.D Radiotherapy

2.Externship

3. Senior Resident

 

4. International     Fellowship

 1. SKIMS, Srinagar,INDIA March 2006.

 2. PGIMER,Chandigarh, INDIA

 3. SKIMS, Srinagar,INDIA till December    2008.

 

4. M.D Anderson Cancer Centre Houston , Texas, U.S.A

CONFERENCES ATTENDED & SCIENTIFIC PAPER/POSTER PRESENTATION

(Non Oncology Conferences attended not mentioned here)

NATIONAL CONFERENCES ATTENDED AROI/ISNO/IASO/ ISGYNAE /UCOST 29
INTERNATIONAL CONFERENCES ATTENDED   06

Paper Presented :

National 29
International 06

Record of last 3 years:

CONFERENCE PRESENTATION
1]. 16th NZAROICON SEPTEMBER 2010, JAMMU. ORAL PRESENTATION: RECURRENT VERSUS RESIDUAL POST EBRT BRAIN TUMOR.
2]. 3rd INDIAN SOCIETY OF NEUROONCOLOGY,ISNO, MARCH 2011,KOLKOTA. ORAL PRESENTATION :PRIMARY PEDIATRIC SPINAL CORD TUMOR.
3]. 17th NZAROICON OCTOBER 2011,GMC, CHANDIGARH. PEDIATRIC SPINAL GBM : A RARE CASE.
4]. NZAROI- ONCOLOGY CME AUG 2011, HIHT,DEHRADUN. BASICS OF RADIATION ONCOLOGY.
5]. 18th NZAROICON SEPTEMBER 2012,BHATINDA. GBM IN ELDERELY PATIENTS
6]. NATIONAL AROICON KOLKOTA 29thNOV-2 DEC 2012 , KOLKOTA. PROGNOSTIC FACTORS IN GBM.
PAPER NO 7]. [SAME AROICON KOLKOTA 2012] PALLIATIVE RT IN SVC.  
8]. UTTARAKHAND STATE SCIENCE &TECHNOLOGY CONGRESS 21ST NOV 2012 CANCER TREATMENT IN GARHWAL: A HOSPITAL BASED STUDY.

Paper/Guest Lecture Presented (INTERNATIONAL CONFERENCES)       (6)

S.No.

Title

Date & Year

Conference

Place

 

 

 

 

 

1

Prognostic factors in Elderely patients with high    grade Gliomas:

21st-24th MARCH 2013

ASNO 2013

MUMBAI

2

IMRT or 3DCRTin brain tumors??  

SEPTEMBER 2014

ASNO 2014

ISTANBUL

3

RTM :Challenge to control lung cancer?

 29th NOVEMBER 2014

SAARC2014

GURGAON

4

EMR in radiotherapy

2ND NOVEMBER 2014

APAMI 2014

AIIMS,DELHI

5

A dosimetric criteria for patient treatment selection : IMRT or 3DCRT ?? ( Selected for award category)

 2nd DECEMBER 2014

RSNA 2014

CHICAGO

6.

Palliative care in Gynaecology cancer

 

7TH July 2017

GYNAEONCO SYMPOSIUM

ROME ITALY

National Conferences (INDIA)  Paper Presented  (29)

S.No.

Title

Date & Year

Conference

Place

  1.  

Clinicopathological profile of Nasopharyngeal malignancies in Kashmir

2/12/2006

AROI

Varanasi

  1.  

Chemopause in Cancer Breast

2006

Indian Menopause Society

Jammu

  1.  

Pediatric  primary  intramedullary  spinal cord Spinal Cord GBM

23rd-24th Oct October 2010

NZAROICON

JAMMU

  1.  

PostRadiation Necrosis or pseudoprogression in brain tumor

8TH-9TH Oct 2011

NZAROICON

CHANDIGARH

  1.  

Basic Principles of radiotherapy

27TH August 2011

ONCOLOGY CME

HIMS, DEHRADUN

  1.  

Radiotherapy in elderly patients with brain tumors

29th-30th September 2012

NZAROICON

BHATINDA

  1.  

Cancer Treatment by Radiotherapy in Garhwal Region

 21st-23 Nov November2012

UCOST

DEHRADUN

  1.  

Palliative radiation therapy in superior vena cava obstruction in patients with advanced  non-small cell lung cancer

December2012

AROICON

KOLKOTA

  1.  

Evaluation of outcome and prognostic factors  in high grade gliomas.

 December 2012

AROICON

KOLKOTA

  1.  

Outcome from computed tomographic based high dose rate brachytherapy

 30TH September 2013

NZAROICON

DEHRADUN

  1.  

High dose rate endobronchial radiotherapy for palliation of lung cancer

21st-24th Nov 2013

ICC DELHI

(2 PAPERS)

ONE NOMINATED FOR G.B PANT AWARD

DELHI

  1.  

 

 

 

 

  1.  

Outcome from computed tomographic based high dose rate brachytherapy

26TH -28TH Dec  2013

UCOST

DDUN

  1.  

Comparision of 3D CRT/IMRT in CA Larynx.

20th-21st September 2014

 

NAZARICON ROHTAK

HARYANA

  1.  

Intraluminal Brachytherapy in cancer lung

 6th Nov 2014,November 2014

AROICON

( PAPER NOMINATED FOR YROC AWARD)

IMPHAL

  1.  

Dosimeteric comparison 3DCRT and IMRT in brain tumors

 4th-6th April 2014

NEUROONCOLOGY 2014

LUCKNOW

  1.  

Video ppt. brachy in cancer lung

14th-16th March2014

IBSCON 2014

DELHI

  1.  

Pannel discussion ovarian tumors

APRIL 2015

 

UTTRAKHAND

SOCIETY OF GYNAECOLOGY

& CRI SRHU

 

DEHRADUN

  1.  

 

Outcome of Radiotherapy   in cancer cervix .

26th February 2015

8thUttarakhand State Science and Technology   Congress 2014

DEHRADUN

  1.  

Dosimeteric comparison of 3DCRT versus IMRT in medulloblastomas

APRIL 2015

ISNOCON KOCHIN

KOCHIN

  1.  

Radiotherapy in cancer endometrium

8th AUGUST 2015

GYNAEONCOLOGY CME 2015

DEHRADUN

  1.  

Dosimeteric comparison of 3DCRT versus IMRT in boost of carcinoma cervix

30th Nov 2015

AROICON

( PAPER NOMINATED FOR YROC AWARD)

LUCKHNOW

  1.  

Outcome of Pediatric High grade Gliomas

April 2016

ISNOCON Hyderabad

Hyderabad

  1.  

The efficacy of an ayurvedic preparation of yashtimadhu (glyeyrrhiza GLABRA) on radiation induced mucositis in head and neck cancer patients; A randomized clinical study

Nov 2016

AROICON Bubneshwar( PAPER NOMINATED FOR YROC AWARD)

 

Bubneshwar

  1.  

 Sharing Vision on Angle of Concavity in Brain Tumors

March 2017

ISNOCON Banglore

(GOT TRAVEL GRANT AWARD)

Banglore

  1.  

Immunotherapy in carcinoma urinary bladder

July 2017

Best Of ASCO (AS PANELIST)

Chandigarh

  1.  

TORS versus CTRT in HPV positive  ca oropharynx

27th August 2017

Max Debates (AS PANELIST)

Delhi

  1.  

Staging of GI malignancies

9th September 2017

Crabecon 2017

Jammu

  1.  

Judge for oral presentation postgraduates

9th September 2017

Crabecon 2017

Jammu

 

 

 

Cancer Treatment

Cancer is no longer a death trap. It is completely curable if detected early. Various advanced treatments are available to cure cancer now. We are able to cure cancer in 70-80 percent of the patients. With the help of technological advancement in radiation oncology and the anti-cancer drugs, we are now treating the affected area instead of the entire organ as it used to be earlier. In Surgery too only the part of organ that has developed cancer is resected and radiation therapy takes care of the remaining at risk areas. Amputation of limbs is avoided. Limb Salvage surgeries and organ spring procedures are now the norm.
Earlier entire breast used to be removed if the breast is affected by cancer, but now the treatment is focused on the lump so that the breast is preserved.
 
Radiation Therapy, Chemotherapy & Surgery
Cancer is dealt by radiation therapy, chemotherapy or surgery. In chemotherapy, anti-cancer agents are used to fight the cancer-affected part of the patient and will prevent cancer cells from growing in other parts of the body. Mostly these drugs are given intravenously.
These drugs may cause some side effects such as hair loss, soreness in the oral cavity, weakness. The immunity of the body may decrease temporarily. Newer drugs have decreased toxicities.
The radiation treatment has seen great advancements in the recent times. Now radiation therapy is minimally toxic and causes only minor side effects. For most cancers, radiation therapy is used effectively.
In Surgery too only the part of organ that has developed cancer is resected and radiation therapy takes care of the remaining at risk areas. Amputation of limbs is avoided. Limb Salvage surgeries and organ spring procedures are now the norm.
Earlier entire breast used to be removed if the breast is affected by cancer, but now the treatment is focused on the lump so that the breast is preserved.
The treatment modality varies from case to case and is decided by Tumor board after a thorough study of the patient. The patient will be educated on all the options available and the treatment will begin only after a consensus is arrived on.

More Articles...

  1. x (2)
  2. x (3)
  3. x (4)
  4. x (5)